Streetbeat News

Stock Prices

REGN

A whale has taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 75% of detected unusual options trades being bearish. Whales have been targeting a price range of $600 to $880 for REGN over the last 3 months. Analysts have mixed ratings, with price targets ranging from $811 to $1050.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 6:31 pm

CHPT

ChargePoint Inc. (NYSE:CHPT) shares are moving higher after BofA Securities upgraded the stock to Buy. Analyst Alex Vrabel cited proof of execution, improved profitability outlook, and consistency since its PIPE offering. ChargePoint holds a 70% market share in the US networked EV chargers market and is expected to benefit from Tesla's crowded SuperCharger network.

Portfolio Pulse from Ryan Gustafson

May 30, 2023 | 6:22 pm

HTHT

H World shares are trading lower following the release of the company's Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 6:21 pm

CRWD

RBC Capital Markets analyst Matthew Hedberg reiterated an Outperform rating on CrowdStrike Holdings, raising the price target to $180 from $170. The company is expected to report its Q1 2024 results on May 31, 2023, with an anticipated EPS of $0.51 and revenues of $676 million. CrowdStrike is in a strong position for cyber-security consolidation, with its TAM expected to expand to $43.6 billion by year-end.

Portfolio Pulse from Nabaparna Bhattacharya

May 30, 2023 | 6:21 pm

NVDA

Nvidia Corporation (NVDA) has joined the $1 trillion market capitalization club after a surge in share price following strong quarterly earnings results and guidance. The company reported Q1 revenue of $7.19 billion, beating estimates, and guided for Q2 revenue to be $11 billion, significantly higher than Street consensus estimates. This led to analysts raising their price targets and predicting a $1 trillion market cap.

Portfolio Pulse from Chris Katje

May 30, 2023 | 6:20 pm

NVDA

Tech and AI-related stocks are trading higher following NVIDIA's Q1 earnings and momentum in AI stocks, as well as a tentative debt ceiling agreement between the Biden administration and Republicans.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 6:19 pm

DHI

A large bearish position on D.R. Horton (NYSE:DHI) has been spotted, with 23 options trades identified, 22 of which are puts totaling $850,331 and 1 call totaling $45,160. Whales have been targeting a price range of $65 to $115 for D.R. Horton over the last 3 months.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 6:16 pm

BMY

NBY

NMRD

SMFL

During Tuesday's morning session, 137 companies made new 52-week lows. Notable companies include Bristol-Myers Squibb, NovaBay Pharmaceuticals, Smart for Life, and Nemaura Medical.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 6:13 pm

CHUY

In the last 3 months, 7 analysts have provided 12-month price targets for Chuy's Holdings (NASDAQ:CHUY), with an average price target of $39.86, up 7.73% from the previous average of $37.00. The ratings include 2 bullish, 3 somewhat bullish, and 2 indifferent.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 6:02 pm

EW

Over the past 3 months, 16 analysts have published their opinion on Edwards Lifesciences (NYSE:EW) stock, with an average 12-month price target of $94.0. The average price target has increased by 4.98% over the past month.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 6:02 pm